Displaying 11–20 of 601 results
May 24, 2021 Eye On the Cure Research News
The gene-agnostic approach is designed to restore some vision to people with advanced vision loss
May 24, 2021 Beacon Stories
Inspired by their troop leader diagnosed with Usher syndrome, Girl Scout Troop 1673 is hoping to change the world, one crosswalk at a time, with their Paint It Yellow challenge.
Sample letter for contacting your Member in the House
May 21, 2021 Industry News
The bill would provide loans to therapy developers ready to launch clinical trials for a broad range of conditions including eye diseases.
May 21, 2021 Press Releases
Legislation provides innovative financing for clinical trials stalled by COVID-19 pandemic.
The bill would provide loans to therapy developers ready to launch clinical trials for a broad range of conditions including retinal and eye diseases.
May 20, 2021 Press Releases
The free webinar for eye care professionals, on June 21, will feature some of the intriguing and innovative research efforts underway for inherited retinal diseases and AMD.
An overview of the Foundation’s no-cost genetic testing program will also be presented.
May 18, 2021 The Foundation in the News
Uses novel, mutation agnostic optogenetics approach to restore vision in underserved forms of blindness. Company backed by leading life science investors including Octagon Capital, Samsara BioCapital and Casdin Capital, along with founding investors Atlas Venture, Mission BioCapital and Foundation Fighting Blindness.
May 14, 2021 Eye On the Cure Research News
More details from the clinical trial will be reported at a later date
May 10, 2021 Eye On the Cure Research News
The company is planning the launch of a Phase 2/3 trial for its XLRP gene therapy